IP Library › Patent Application 14097928
Patent Application Utility
App. No. 14/097,928 · Confirmation No. 5631

RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS

Applicant: Novartis AG
Abandoned -- Incomplete Application (Pre-examination) View Publication ↗
⬇ PDF
 Code Description Pages PDF
2014-09-02 ABN Abandonment 2 View
2014-04-03 NTC.PUB Notice of Publication 1 View
2013-12-26 N572 Response - Re: Informal Power of Attorney (PTOL-308) 1 View
2013-12-26 M327 Miscellaneous Communication to Applicant - No Action Count 1 View
2013-12-26 APP.FILE.REC Filing Receipt 3 View
2013-12-26 NTC.MISS.PRT Notice to File Missing Parts 2 View
2013-12-26 WFEE Fee Worksheet (SB06) 1 View
2013-12-16 CRFE Sequence Listing in Computer Readable Format, No errors found 14 View
2013-12-09 PA.. Power of Attorney 1 View
2013-12-09 R3.73 Assignee showing of ownership per 37 CFR 3.73 2 View
2013-12-09 N417 Electronic Filing System Acknowledgment Receipt 2 View
2013-12-05 SEQ.TXT Sequence Listing (Text File) 1 View
2013-12-05 SPEC Specification 19 View
2013-12-05 CLM Claims 4 View
2013-12-05 ABST Abstract 1 View
2013-12-05 DRW Drawings-only black and white line drawings 3 View
2013-12-05 ADS Application Data Sheet 7 View
2013-12-05 CRFS CRF Statement that Sequence Listing text file (CRF) and paper/pdf Sequence Listing are the same 1 View
2013-12-05 SEQLIST Sequence Listing 10 View
2013-12-05 WFEE Fee Worksheet (SB06) 2 View
2013-12-05 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
14/097,928
Filed
2013-12-05
Pub. No.
US20140094502A1
Art Unit
1674